These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23761067)

  • 1. 'A brave but vital initiative': reining in corporate harm.
    Malone RE
    Tob Control; 2013 Jul; 22(4):217. PubMed ID: 23761067
    [No Abstract]   [Full Text] [Related]  

  • 2. Breathing life into the Framework Convention on Tobacco Control: smoking cessation and the right to health.
    Meier BM
    Yale J Health Policy Law Ethics; 2005; 5(1):137-92. PubMed ID: 15742577
    [No Abstract]   [Full Text] [Related]  

  • 3. Making a human right to tobacco control: expert and advocacy networks, framing and the right to health.
    Reubi D
    Glob Public Health; 2012; 7 Suppl 2():S176-90. PubMed ID: 23088214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missing the biggest story in the US Surgeon General's report.
    Malone RE
    Tob Control; 2014 Mar; 23(2):91-2. PubMed ID: 24523300
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the impact of U.S. and Canadian cigarette pack warning label requirements on tobacco industry profitability and the public health.
    Givel M
    Health Policy; 2007 Oct; 83(2-3):343-52. PubMed ID: 17239485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco control and health equality.
    Slama K
    Glob Health Promot; 2010 Mar; 17(1 Suppl):3-6, 81-5, 91-5. PubMed ID: 20595349
    [No Abstract]   [Full Text] [Related]  

  • 7. Advocacy in action: extreme corporate makeover interruptus: denormalising tobacco industry corporate schmoozing.
    Chapman S
    Tob Control; 2004 Dec; 13(4):445-7. PubMed ID: 15564635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A law for "minorities" consumer advocacy].
    Mihălţan F
    Pneumologia; 2008; 57(3):182-3. PubMed ID: 18998334
    [No Abstract]   [Full Text] [Related]  

  • 9. Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003.
    Wakefield M; Szczypka G; Terry-McElrath Y; Emery S; Flay B; Chaloupka F; Saffer H
    Addiction; 2005 Dec; 100(12):1875-83. PubMed ID: 16367989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the insidious health and financial burden of tobacco use in Missouri: the role of medical and public health professionals.
    Everett KD; Bullock L; Longo DR
    Mo Med; 2006; 103(2):175-9. PubMed ID: 16703720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco and health.
    CMAJ; 1997 Jan; 156(2):240A-240F. PubMed ID: 9012730
    [No Abstract]   [Full Text] [Related]  

  • 13. [FCTC (Framework Convention on Tobacco Control)--the opening of the attack against great tobacco producers].
    Mihălţan F
    Pneumologia; 2005; 54(1):39-40. PubMed ID: 16193733
    [No Abstract]   [Full Text] [Related]  

  • 14. Forecasting future tobacco control policy: where to next?
    Freeman B; Gartner C; Hall W; Chapman S
    Aust N Z J Public Health; 2010 Oct; 34(5):447-50. PubMed ID: 21040170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engendering tobacco control: using an international public health treaty to reduce smoking and empower women.
    Greaves L; Tungohan E
    Tob Control; 2007 Jun; 16(3):148-50. PubMed ID: 17565123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication is a determinant of public health: a media campaign for tobacco control in India.
    Duella CS
    BMJ; 2013 Oct; 347():f6275. PubMed ID: 24136636
    [No Abstract]   [Full Text] [Related]  

  • 17. Public health advocacy to change corporate practices: implications for health education practice and research.
    Freudenberg N
    Health Educ Behav; 2005 Jun; 32(3):298-319; discussion 355-62. PubMed ID: 15851541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate.
    Callard C; Thompson D; Collishaw N
    Tob Control; 2005 Aug; 14(4):278-83. PubMed ID: 16046692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing tobacco harm: research challenges and issues.
    Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.